Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05003856 · ClinicalTrials.gov registry record · NA
Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05003856: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT05003856 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05003856, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This phase IV trial studies the effect of radiofrequency ablation in treating patients with benign or low risk thyroid nodule. Radiofrequency ablation uses a needle to deliver a high-frequency electric current to kill tumor cells by heating them. The goal of this research study is to learn if ultrasound guided radiofrequency ablation can provide the same treatment result as standard surgical removal of the thyroid nodule, small primary thyroid, or thyroid cancers that have come back. Researchers also want to learn if the procedure can be less invasive and perhaps provide a better recovery response than surgery.
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Radiofrequency Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-08-29 |
| Est. Completion | 2025-03-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05003856
The ClinicalTrials.gov registry entry for NCT05003856 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quality-of-Life Assessment is the first listed.
NCT05003856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05003856 about?
NCT05003856 is a clinical study titled "Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule". This phase IV trial studies the effect of radiofrequency ablation in treating patients with benign or low risk thyroid nodule. Radiofrequency ablation uses a needle to deliver a high-frequency electric current to kill tumor cells by heating them. The goal of this research study is to learn if ultras...
What is the current status of trial NCT05003856?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-08-29. Estimated completion is 2025-03-27.
What interventions are being tested in trial NCT05003856?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Radiofrequency Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT05003856?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.